Penny Melissa A, Camponovo Flavia, Chitnis Nakul, Smith Thomas A, Tanner Marcel
Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
Parasite Epidemiol Control. 2020 May 6;10:e00145. doi: 10.1016/j.parepi.2020.e00145. eCollection 2020 Aug.
Malaria burden has significantly changed or decreased over the last 20 years, however, it remains an important health problem requiring the rigorous application of existing tools and approaches, as well as the development and use of new interventions. A malaria vaccine has long been considered a possible new intervention to aid malaria burden reduction. However, after decades of development, only one vaccine to protect children has completed phase 3 studies. Before being widely recommended for use, it must further demonstrate safety, impact and feasibility in ongoing pilot implementation studies. Now is an appropriate time to consider the use-cases and health targets of future malaria vaccines. These must be considered in the context of likely innovations in other malaria tools such as vector control, as well as the significant knowledge gaps on the appropriate target antigens, and the immunology of vaccine-induced protection. Here we discuss the history of malaria vaccines and suggest some future use-cases for future malaria vaccines that will support achieving malaria health goals in different settings.
在过去20年里,疟疾负担已显著改变或减轻,然而,它仍然是一个重要的健康问题,需要严格应用现有工具和方法,以及开发和使用新的干预措施。长期以来,疟疾疫苗一直被视为一种可能有助于减轻疟疾负担的新干预措施。然而,经过数十年的研发,只有一种保护儿童的疫苗完成了3期研究。在被广泛推荐使用之前,它必须在正在进行的试点实施研究中进一步证明其安全性、效果和可行性。现在是考虑未来疟疾疫苗的使用案例和健康目标的适当时机。这些必须结合其他疟疾工具(如病媒控制)可能的创新,以及在合适的靶抗原和疫苗诱导保护的免疫学方面存在的重大知识空白来考虑。在此,我们讨论疟疾疫苗的历史,并为未来疟疾疫苗提出一些未来使用案例,这些案例将有助于在不同环境中实现疟疾健康目标。